嘧啶-吡嗪-恶唑类查尔酮抗癌剂的设计、合成和生物学评价

IF 2.218 Q2 Chemistry Chemical Data Collections Pub Date : 2024-03-01 DOI:10.1016/j.cdc.2024.101128
G. Sabita , R. Savitha , K. Divya , E. Shivakumar , K. Bhaskar
{"title":"嘧啶-吡嗪-恶唑类查尔酮抗癌剂的设计、合成和生物学评价","authors":"G. Sabita ,&nbsp;R. Savitha ,&nbsp;K. Divya ,&nbsp;E. Shivakumar ,&nbsp;K. Bhaskar","doi":"10.1016/j.cdc.2024.101128","DOIUrl":null,"url":null,"abstract":"<div><p>A new series of chalcone incorporated pyrimidine-pyrazine-oxazole (<strong>9a-j</strong>) compounds and their structures were confirmed by <sup>1</sup>HNMR, <sup>13</sup>CNMR and mass spectral data. All compounds assessed for their preliminary anticancer applications towards four human cancer cell lines like SiHa (human cervix cancer), A549 (human lung cancer), MCF-7 (human breast cancer) and Colo-205 (human colon cancer) by using of the MTT assay used the well-known chemotherapeutic agent etoposide as a positive control. According to the obtained data, most of the tested compounds displayed stronger activity compared with etoposides. Among the five compounds <strong>9a, 9b, 9c, 9d</strong> and <strong>9e</strong> possessed the most promising activities in all cell lines. Predominantly, two compounds <strong>9a</strong> and <strong>9b</strong> showed the highest anticancer activity.</p></div>","PeriodicalId":269,"journal":{"name":"Chemical Data Collections","volume":"51 ","pages":"Article 101128"},"PeriodicalIF":2.2180,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis and biological evaluation of chalcone incorporated of Pyrimidine-Pyrazine-Oxazoles as anticancer agents\",\"authors\":\"G. Sabita ,&nbsp;R. Savitha ,&nbsp;K. Divya ,&nbsp;E. Shivakumar ,&nbsp;K. Bhaskar\",\"doi\":\"10.1016/j.cdc.2024.101128\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A new series of chalcone incorporated pyrimidine-pyrazine-oxazole (<strong>9a-j</strong>) compounds and their structures were confirmed by <sup>1</sup>HNMR, <sup>13</sup>CNMR and mass spectral data. All compounds assessed for their preliminary anticancer applications towards four human cancer cell lines like SiHa (human cervix cancer), A549 (human lung cancer), MCF-7 (human breast cancer) and Colo-205 (human colon cancer) by using of the MTT assay used the well-known chemotherapeutic agent etoposide as a positive control. According to the obtained data, most of the tested compounds displayed stronger activity compared with etoposides. Among the five compounds <strong>9a, 9b, 9c, 9d</strong> and <strong>9e</strong> possessed the most promising activities in all cell lines. Predominantly, two compounds <strong>9a</strong> and <strong>9b</strong> showed the highest anticancer activity.</p></div>\",\"PeriodicalId\":269,\"journal\":{\"name\":\"Chemical Data Collections\",\"volume\":\"51 \",\"pages\":\"Article 101128\"},\"PeriodicalIF\":2.2180,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical Data Collections\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405830024000168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Chemistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Data Collections","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405830024000168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 0

摘要

通过 1HNMR、13CNMR 和质谱数据确认了一系列新的查尔酮嘧啶吡嗪噁唑(9a-j)化合物及其结构。所有化合物都采用 MTT 试验,以著名的化疗药物依托泊苷为阳性对照,对 SiHa(人宫颈癌)、A549(人肺癌)、MCF-7(人乳腺癌)和 Colo-205(人结肠癌)等四种人癌细胞系进行了初步抗癌应用评估。根据获得的数据,与依托泊苷相比,大多数受试化合物都显示出更强的活性。在五种化合物中,9a、9b、9c、9d 和 9e 在所有细胞系中都具有最有前途的活性。主要是 9a 和 9b 这两种化合物的抗癌活性最高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Design, synthesis and biological evaluation of chalcone incorporated of Pyrimidine-Pyrazine-Oxazoles as anticancer agents

A new series of chalcone incorporated pyrimidine-pyrazine-oxazole (9a-j) compounds and their structures were confirmed by 1HNMR, 13CNMR and mass spectral data. All compounds assessed for their preliminary anticancer applications towards four human cancer cell lines like SiHa (human cervix cancer), A549 (human lung cancer), MCF-7 (human breast cancer) and Colo-205 (human colon cancer) by using of the MTT assay used the well-known chemotherapeutic agent etoposide as a positive control. According to the obtained data, most of the tested compounds displayed stronger activity compared with etoposides. Among the five compounds 9a, 9b, 9c, 9d and 9e possessed the most promising activities in all cell lines. Predominantly, two compounds 9a and 9b showed the highest anticancer activity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chemical Data Collections
Chemical Data Collections Chemistry-Chemistry (all)
CiteScore
6.10
自引率
0.00%
发文量
169
审稿时长
24 days
期刊介绍: Chemical Data Collections (CDC) provides a publication outlet for the increasing need to make research material and data easy to share and re-use. Publication of research data with CDC will allow scientists to: -Make their data easy to find and access -Benefit from the fast publication process -Contribute to proper data citation and attribution -Publish their intermediate and null/negative results -Receive recognition for the work that does not fit traditional article format. The research data will be published as ''data articles'' that support fast and easy submission and quick peer-review processes. Data articles introduced by CDC are short self-contained publications about research materials and data. They must provide the scientific context of the described work and contain the following elements: a title, list of authors (plus affiliations), abstract, keywords, graphical abstract, metadata table, main text and at least three references. The journal welcomes submissions focusing on (but not limited to) the following categories of research output: spectral data, syntheses, crystallographic data, computational simulations, molecular dynamics and models, physicochemical data, etc.
期刊最新文献
One-pot synthesis of multifunctional magnetic activated carbon from fallen saman leaves to activate persulfate for acid red 18 degradation Interfacial properties, and micellization of surface-active ionic liquid in presence of polymeric solutions Design, synthesis, characterization, invitro anticancer evaluation, computational studies, and in silico ADME assessment of New N-(5-o-tolyl-1,3,4-oxadiazol-2-yl) alkanamides Chemical characterization, antioxidant activity and toxicity of sugars present in Annona cornifolia (Annonaceae) seeds A rapid, efficient microwave-assisted synthesis of novel bis-pyrazole analogues using non-toxic and cost-effective catalyst under green solvent medium
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1